the effect of Hepatitis B vaccination in patients with chronic kidney disease
Not Applicable
- Conditions
- Chronic renal failure.Chronic renal failure
- Registration Number
- IRCT138905163325N4
- Lead Sponsor
- Zanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 51
Inclusion Criteria
Age more than18 years old, presence of Chronic Kidney Disease in the stages of 2 to 4
Exclusion criteria: Presence of severe CKD which is predicted to result in end stage renal disease over a year, HBV positive, presence of lymphoprolifrative disease, receiving immunosuppressive drugs, previous HBV vaccination
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum HBSAb. Timepoint: 3 months after the last dose of vaccination. Method of measurement: Laboratory kits.
- Secondary Outcome Measures
Name Time Method HBS Ag. Timepoint: 3 months after the last dose ofl anti HBV vaccination. Method of measurement: Laboratory kits.